Journalartikel
Autorenliste: Rosellen, Jens; Diemer, Thorsten; Hauptmann, Arne; Wagenlehner, Florian
Jahr der Veröffentlichung: 2022
Seiten: 1260-1275
Zeitschrift: Die Urologie
Bandnummer: 61
Heftnummer: 11
ISSN: 2731-7064
eISSN: 2731-7072
DOI Link: https://doi.org/10.1007/s00120-022-01957-7
Verlag: Springer
Abstract:
Male hypogonadism is a congenital or acquired disorder that exerts a negative influence on various organ functions and can massively impair the quality of life through the relative or absolute deficiency of testosterone. A variety of preparations are available for substitution treatment, which differ in administration form and intake interval. For the execution of testosterone treatment various guidelines exist with clear and practical instructions on the indications, contraindications, treatment procedure and monitoring. Of particular importance are cardiovascular aspects and diseases of the prostate gland, which underlines the central position of the urologist in the treatment.
Zitierstile
Harvard-Zitierstil: Rosellen, J., Diemer, T., Hauptmann, A. and Wagenlehner, F. (2022) Testosterone treatment, Die Urologie, 61(11), pp. 1260-1275. https://doi.org/10.1007/s00120-022-01957-7
APA-Zitierstil: Rosellen, J., Diemer, T., Hauptmann, A., & Wagenlehner, F. (2022). Testosterone treatment. Die Urologie. 61(11), 1260-1275. https://doi.org/10.1007/s00120-022-01957-7
Schlagwörter
GUIDELINES; Hormone replacement therapy; HYPOGONADISM; LATE-ONSET HYPOGONADISM; LOW SERUM TESTOSTERONE; OLDER MEN; PROSTATE-CANCER; RECOMMENDATIONS; REPLACEMENT THERAPY; sexual function; Testosterone deficiency; VENOUS THROMBOEMBOLISM
